Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms.

Deng M, Zhang W, Tang H, Ye Q, Liao Q, Zhou Y, Wu M, Xiong W, Zheng Y, Guo X, Qin Z, He W, Zhou M, Xiang J, Li X, Ma J, Li G.

Oncogene. 2013 Sep 5;32(36):4273-83. doi: 10.1038/onc.2012.434. Epub 2012 Oct 15.

PMID:
23069661
2.

miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.

Deng M, Ye Q, Qin Z, Zheng Y, He W, Tang H, Zhou Y, Xiong W, Zhou M, Li X, Yan Q, Ma J, Li G.

Tumour Biol. 2013 Jun;34(3):1793-800. doi: 10.1007/s13277-013-0718-y. Epub 2013 Mar 13.

PMID:
23479198
3.

Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines.

Zhang H, Feng X, Liu W, Jiang X, Shan W, Huang C, Yi H, Zhu B, Zhou W, Wang L, Liu C, Zhang L, Jia W, Huang W, Li G, Shi J, Wanggou S, Yao K, Ren C.

J Cell Biochem. 2011 Jul;112(7):1832-43. doi: 10.1002/jcb.23101.

PMID:
21400573
4.

Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway.

Zhou Y, Zeng Z, Zhang W, Xiong W, Wu M, Tan Y, Yi W, Xiao L, Li X, Huang C, Cao L, Tang K, Li X, Shen S, Li G.

Int J Cancer. 2008 Nov 1;123(9):2065-72. doi: 10.1002/ijc.23727.

5.

14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.

Yang H, Zhao R, Lee MH.

Mol Cancer Ther. 2006 Feb;5(2):253-60.

6.

Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma.

Yi HM, Li H, Peng D, Zhang HJ, Wang L, Zhao M, Yao KT, Ren CP.

Oncol Res. 2006;16(6):261-72.

PMID:
17476971
7.

Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma.

Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S, Long X, Jiang Q, Song Y, Cheng C, Wang H, Zhao M, Fu Q, Lyu X, Chen Y, Fan Y, Liu Y, Li X, Fang W.

Cell Death Dis. 2013 Oct 24;4:e872. doi: 10.1038/cddis.2013.376.

8.

Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma.

Yu X, Zhen Y, Yang H, Wang H, Zhou Y, Wang E, Marincola FM, Mai C, Chen Y, Wei H, Song Y, Lyu X, Ye Y, Cai L, Wu Q, Zhao M, Hua S, Fu Q, Zhang Y, Yao K, Liu Z, Li X, Fang W.

Cell Death Dis. 2013 May 16;4:e634. doi: 10.1038/cddis.2013.153. Erratum in: Cell Death Dis. 2013;4:e672.

9.

Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma.

Zhang W, Fan S, Zou G, Shi L, Zeng Z, Ma J, Zhou Y, Li X, Zhang X, Li X, Tan M, Xiong W, Li G.

Tumour Biol. 2015 Feb;36(2):675-83. doi: 10.1007/s13277-014-2650-1. Epub 2014 Oct 7.

PMID:
25286756
10.

Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity.

Hwang CF, Chien CY, Huang SC, Yin YF, Huang CC, Fang FM, Tsai HT, Su LJ, Chen CH.

J Pathol. 2010 Dec;222(4):367-79. doi: 10.1002/path.2776.

PMID:
20927779
11.

[Expression, genetic and epigenetic alterations of LTF gene in nasopharyngeal carcinoma cell lines].

Yi HM, Li YC, Zhong RH.

Zhonghua Zhong Liu Za Zhi. 2010 Oct;32(10):729-33. Chinese.

PMID:
21163060
12.

MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/β-catenin signaling pathway.

Meng F, Li H, Shi H, Yang Q, Zhang F, Yang Y, Kang L, Zhen T, Dai S, Dong Y, Han A.

PLoS One. 2013;8(4):e60821. doi: 10.1371/journal.pone.0060821. Epub 2013 Apr 3.

13.

Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes.

Zhou Y, Wang W, Zheng D, Peng S, Xiong W, Ma J, Zeng Z, Wu M, Zhou M, Xiang J, Xiang B, Li X, Li X, Li G.

Med Oncol. 2012 Sep;29(3):1456-62. doi: 10.1007/s12032-011-0079-6. Epub 2011 Oct 20.

PMID:
22011934
14.

Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.

Wong AM, Kong KL, Chen L, Liu M, Wong AM, Zhu C, Tsang JW, Guan XY.

Int J Cancer. 2013 Nov 15;133(10):2284-95. doi: 10.1002/ijc.28252. Epub 2013 Jul 13.

15.
16.

Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.

Tu L, Liu Z, He X, He Y, Yang H, Jiang Q, Xie S, Xiao G, Li X, Yao K, Fang W.

Mol Cancer. 2010 Apr 16;9:78. doi: 10.1186/1476-4598-9-78.

17.

Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.

Hwang CF, Shiu LY, Su LJ, Yu-Fang Yin, Wang WS, Huang SC, Chiu TJ, Huang CC, Zhen YY, Tsai HT, Fang FM, Huang TL, Chen CH.

PLoS One. 2013 Dec 27;8(12):e84218. doi: 10.1371/journal.pone.0084218. eCollection 2013.

18.

IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling.

Phoon YP, Cheung AK, Cheung FM, Chan KF, Wong S, Wong BW, Tung SY, Yau CC, Ng WT, Lung ML.

Int J Cancer. 2016 Jan 1;138(1):160-70. doi: 10.1002/ijc.29702. Epub 2015 Aug 10.

19.

Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells.

Wan XB, Long ZJ, Yan M, Xu J, Xia LP, Liu L, Zhao Y, Huang XF, Wang XR, Zhu XF, Hong MH, Liu Q.

Carcinogenesis. 2008 Oct;29(10):1930-7. doi: 10.1093/carcin/bgn176. Epub 2008 Jul 30.

PMID:
18667445
20.

Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines.

Ma BB, Lui VW, Hui CW, Lau CP, Wong CH, Hui EP, Ng MH, Tsao SW, Li Y, Chan AT.

Invest New Drugs. 2013 Jun;31(3):567-75. doi: 10.1007/s10637-012-9896-5. Epub 2012 Nov 11.

PMID:
23143779

Supplemental Content

Support Center